TNFRSF10C

TNF receptor superfamily member 10c, the group of CD molecules|Tumor necrosis factor receptor superfamily

Basic information

Region (hg38): 8:23102921-23117445

Links

ENSG00000173535NCBI:8794OMIM:603613HGNC:11906Uniprot:O14798AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TNFRSF10C gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF10C gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
2
clinvar
3
missense
6
clinvar
5
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 6 6 2

Variants in TNFRSF10C

This is a list of pathogenic ClinVar variants found in the TNFRSF10C region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-23103164-G-T Likely benign (May 04, 2018)732374
8-23111721-T-A not specified Uncertain significance (May 07, 2024)3327484
8-23111736-C-A not specified Uncertain significance (Nov 10, 2023)3180219
8-23111747-C-T not specified Uncertain significance (Dec 19, 2022)2337476
8-23111769-A-C not specified Uncertain significance (Sep 01, 2021)2248421
8-23111803-C-A not specified Likely benign (Mar 07, 2023)2495141
8-23111807-G-A not specified Uncertain significance (Mar 19, 2024)3327482
8-23114662-C-G not specified Uncertain significance (Jul 19, 2023)2595179
8-23114694-G-A Benign (Mar 05, 2018)709419
8-23114707-G-T not specified Uncertain significance (Jul 17, 2023)2612328
8-23114715-C-T Benign (Jul 06, 2018)717706
8-23114722-G-A not specified Likely benign (Nov 03, 2022)2343970
8-23115599-G-A not specified Uncertain significance (Jul 20, 2021)2238629
8-23116718-A-G not specified Likely benign (May 24, 2023)2510506
8-23116765-C-T Likely benign (Jul 01, 2022)2658478
8-23116857-G-C Likely benign (Nov 01, 2022)2658479

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TNFRSF10Cprotein_codingprotein_codingENST00000356864 533083
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000003160.19612501447301257480.00292
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8191211490.8110.000007781677
Missense in Polyphen4135.8541.1435427
Synonymous1.883552.30.6690.00000265521
Loss of Function-0.23587.311.093.08e-791

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002870.00287
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0008320.000832
European (Non-Finnish)0.005460.00544
Middle Eastern0.000.00
South Asian0.00003420.0000327
Other0.003100.00310

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.;
Pathway
Influenza A - Homo sapiens (human);Necroptosis - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Measles - Homo sapiens (human);Apoptosis - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Apoptosis Modulation and Signaling;TP53 Regulates Transcription of Cell Death Genes;VEGFA-VEGFR2 Signaling Pathway;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;Transcriptional Regulation by TP53;Direct p53 effectors;TRAIL signaling pathway;TP53 Regulates Transcription of Death Receptors and Ligands (Consensus)

Intolerance Scores

loftool
0.605
rvis_EVS
0.57
rvis_percentile_EVS
81.99

Haploinsufficiency Scores

pHI
0.0857
hipred
N
hipred_score
0.112
ghis
0.437

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.287

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tnfrsf10b
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; neoplasm;

Gene ontology

Biological process
TRAIL-activated apoptotic signaling pathway;regulation of apoptotic process;positive regulation of apoptotic process
Cellular component
plasma membrane;cell surface;anchored component of membrane
Molecular function
transmembrane signaling receptor activity;TRAIL binding